Spin off
-
Aligen Therapeutics.
Company focused on cardiovascular diseasesAligen Therapeutics is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Aligen holds licenses of CIMA’s patents and know-how on cardiovascular research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.
TEASER: "New antihemorrhagic agents: a novel antifibrinolytic strategy"
Contact:
Jesús Hernández, Sole Administrator.
Julen Oyarzabal, CIMA, Translational Sciences Director.
Business Development Unit: bdcima@unav.es
-
Epical Biosciences.
Company focused on cancer researchEpical Biosciences is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Epical Biosciences holds licenses of CIMA’s patents and know-how on cancer research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.
TEASER: "New epigenetic agents: therapeutic approach in cancer"
Contact:
Jesús Hernández, Sole Administrator.
Julen Oyarzabal, CIMA, Translational Sciences Director.
Business Development Unit: bdcima@unav.es
Business development |
|
Contacto:
Centro de Investigación Médica Aplicada (CIMA) Avenida Pío XII, 55 31008 Pamplona España +34 948 194 700 bdcima@unav.es |